A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...

It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.

Dementia, including Alzheimer’s disease and related disorders, is one of the fastest-growing public health concerns globally.

Additionally, there is some evidence that these drugs can reduce levels of amyloid-beta and tau proteins in the brain — the ...

As the Trump administration makes cuts to federal health agencies, some Alzheimer's experts are worried about the impact on ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

1:54 GLP-1 drugs like Ozempic, Wegovy reduce Alzheimer’s risk for those with diabetes Two major studies published Monday in JAMA Neurology found that GLP-1 medications are linked to a lower risk ...

Share on Pinterest Common antidiabetes drugs could help lower Alzheimer’s risk, increasing evidence suggests. Image credit: mbbirdy/Getty Images. A new study investigates the relationship ...

A major new study finds that certain diabetes medications, including GLP-1 and SGLT2 inhibitors, may be linked to a reduced ...

While newly approved Alzheimer's drugs like lecanemab and aducanumab have garnered attention, concerns over their effectiveness and safety remain. This has intensified interest in repurposing ...

Obesity and diabetes drugs, particularly semaglutides like Wegovy and Ozempic, may reduce a person’s risk of dementia, a new ...